Terns’ oral weight-loss drug has shown promising results in early-stage studies
Terns Pharmaceuticals said its oral obesity drug reduced weight by an average of 4.9 per cent in an early-stage study, joining drugmakers vying for a share of the lucrative weight-loss market, and its shares rose 27 per cent on Monday.
ENTRADAS POPULARES
Bluetongue outbreak in a Portuguese sheep farm has broken out
septiembre 19, 2024
Austria says disaster fund to rise to 1 billion euros
septiembre 19, 2024
Portugal gets help from Spain and Morocco in response to fires
septiembre 19, 2024
Drought reduces Amazon rivers to historic lows
septiembre 19, 2024
TRANSMISIÓN EN VIVO